Novel Biomarkers and Precision Medicine in Gynecologic Malignancies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 17
Special Issue Editor
Interests: clinical trials; inherited mutation; genomic landscape; ovarian cancer; gynecologic cancer; precision medicine; tumor screening
Special Issue Information
Dear Colleagues,
Biomedicines focus on molecular biology and experimental medicine. This Special Issue explores transformative approaches in the management of gynecologic malignancies (ovarian, cervical, and endometrial cancers or other rare malignancies) through precision medicine paradigms. Key focus areas include early detection and screening, biomarker innovations, AI-driven solutions, therapeutic advancements, and potential clinical trial development based on experimental studies. This collection aims to bridge translational research with clinical practice, highlighting strategies to overcome heterogeneity challenges and optimize patient stratification. We hope to illustrate the landscape of current personalized medicine and future development strategies for gynecological cancer treatment.
Dr. Zheng Feng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical trials
- genomic landscape
- targeted therapy
- liquid biopsy
- tumor screening
- biomarker research
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
